Iatrogenic hypothyroidism and postpartum hyperthyroidism in familial dysalbuminaemic hyperthyroxinaemia Familial dysalbuminaemic hyperthyroxinaemia is an autosomal dominant condition caused by enhanced binding of thyroid hormone by abnormal albumin. I2 The condition may be confused with hyperthyroidism because the total thyroxine concentration and free thyroxine index are increased,3 as also may be the free thyroxine concentration measured by some labelled analogue techniques-for example, the Amerlex kit.34 We report a case of familial dysalbuminaemic hyperthyroxinaemia that caused particular problems because hyperthyroidism was initially and probably mistakenly diagnosed; subsequently the patient developed Graves' disease.
Case report
The patient was first seen when 9 years old because of lassitude and failure to gain weight. Her mother, who was euthyroid, had had a benign thyroid nodule removed, and her maternal grandmother had myxoedema. The patient had a twin Serum total and free thyroxine, total and free triiodothyronine, thyroid stimulating hormone, and thyroid stimulating hormone receptor antibody concentrations and ratio of total thyroxine to thyroxine binding globulin in patient with familial dysalbuminaemic hyperthyroxinaemia who developed Graves' disease after pregnancy Conversion: SI to traditional units-Total thyroxine: 1 nmol/1-0-08 og/100 ml. Free thyroxine: 1 pmol/1/0-8 pg/ml. Total triiodothyronine: 1 nmolll-0-7 ng/ml. Free triiodothyronine:
1 pmol/1-0-7 pg/ml.
brother. She was under the third centile for weight and on the 10th centile for height; her intelligence quotient was 73. Results of physical examination were otherwise normal. Serum total thyroxine concentration was 183 nmol/l (14-6 tg/ 100 ml) (adult normal range 60-135 nmol/l; 4-8-10-8 Rg/100 ml). Thyroid antibody values were negative. In 1982 at the age of 17 she complained of increased appetite and restlessness. She did not have a goitre. Investigations showed the serum total thyroxine concentration and ratio of total thyroxine to thyroxine binding globulin to be increased (table); thyroid microsomal antibodies were present (titre 1/1600). After treatment with carbimazole 30 mg for three months a goitre developed and she was lethargic. Serum total.thyroxine concentration was normal but the thyroid stimulating hormone concentration (Sucrosep immunoradiometric assay, Boots-Ceiltech) very high (table). Carbimazole was therefore stopped, at about which time she became pregnant. Familial dysalbuminaemic hyperthyroxinaemia was confirmed by reverse flow electrophoresis of serum trace labelled with iodine-125 thyroxine in the patient and her twin brother but not her mother. The proportional distribution of radioactivity in the patient's serum showed abnormal carriage of the hormone by albumin (prealbumin 15%, albumin 48%, thyroxine binding globulin 37%), as opposed to normal values seen in her mother (prealbumin 15%, albumin 8%, thyroxine binding globulin 77%).
Thyroid treatment was not given during pregnancy, which proceeded uneventfully to term. Serum total thyroxine concentration rose during pregnancy to 312 nmol/l (25-0 ,g/100 ml). Seven months later she presented with increased appetite, sweating, weight loss, difficulty in sleeping, and goitre. Serum total thyroxine and total triiodothyronine concentrations were 380 nmol/l (30 4 ,g/ 100 ml) and 7-4 nmol/l (5-2 ng/ml) respectively. Until this time thyroid stimulating hormone concentrations had been normal on all of several occasions (including retrospective analysis of serum taken before carbimazole was first given) and thyroid stimulating hormone receptor antibodies persistently undetectable. Hyperthyroidism due to Graves' disease was confirmed by a thyroid stimulating hormone concentration of <0 07 mU/l and a thyroid stimulating hormone receptor antibody concentration of 29-7% (expressed as inhibition of binding of thyroid stimulating hormone to control receptors). Carbimazole was restarted with symptomatic improvement.
Comment
Patients with familial dysalbuminaemic hyperthyroxinaemia who undergo tests to exclude hyperthyroidism are at particular risk of being misdiagnosed.2 5 This patient had a family history suggestive of autoimmune thyroid disease and a positive thyroid antibody titre so the development of hyperthyroidism was not surprising. The clinical diagnosis of hyperthyroidism due to Graves' disease was supported by a total triiodothyronine concentration much higher than had previously been recorded and the appearance of thyroid stimulating hormone receptor antibodies.
Over 18 months we identified three more, apparently unrelated patients with familial dysalbuminaemic hyperthyroxinaemia, which suggests that the condition is not particularly uncommon. Over this same 18 months newly diagnosed hyperthyroidism was confirmed biochemically in 120 patients. Thus the proportion of patients in whom thyroxine measurements might at first suggest hyperthyroidism but who in fact have familial dysalbuminaemic hyperthyroxinaemia may be at least 3%.
